menu
    • menu

    Company profile for Intergalactic Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Intergalactic Therapeutics was founded by ATP (Apple Tree Partners), a leading life sciences venture capital firm, to overcome the limitations of viral-based gene therapy and develop a best-in-class non-viral alternative. Intergalactic uses synthetic biology and engineered gene circuits to make covalently closed and circular DNA (“C3DNA”) molecules designed to deliver a potentially safer and more effective solution for pat...
    Intergalactic Therapeutics was founded by ATP (Apple Tree Partners), a leading life sciences venture capital firm, to overcome the limitations of viral-based gene therapy and develop a best-in-class non-viral alternative. Intergalactic uses synthetic biology and engineered gene circuits to make covalently closed and circular DNA (“C3DNA”) molecules designed to deliver a potentially safer and more effective solution for patients.. However, the development of new gene therapies has been beset by safety issues, technical obstacles, and manufacturing cost challenges that have so far restricted their use to a small subset of diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intergalactic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    40 Guest St, Boston, Massachusetts 02135
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intergalactictx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/intergalactic-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intergalactic to Present Updated Data From Its Non-Viral Gene Therapy
    Intergalactic to Present Updated Data From Its Non-Viral Gene Therapy

    20 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intergalactic-therapeutics-to-present-updated-data-from-its-non-viral-gene-therapy-platform-at-the-2023-retinal-cell-and-gene-therapy-innovation-summit-301803069.html

    PR NEWSWIRE
    20 Apr 2023
    Share Share
    Intergalactic Announces Positive Results of Non-Viral Gene Therapy Platform
    Intergalactic Announces Positive Results of Non-Viral Gene Therapy Platform

    15 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intergalactic-therapeutics-announces-positive-preclinical-results-of-its-non-viral-gene-therapy-platform-in-abca4-retinopathies-301772407.html

    PR NEWSWIRE
    15 Mar 2023
    Share Share
    Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch
    Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch

    07 Dec 2021

    // Emmy Lucas FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/apple-tree-partners-breaks-into-uk-biotech-adendra-therapeutics-launch-raises-53m-series-a

    Emmy Lucas FIERCEBIOTECH
    07 Dec 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search